Gene · 4014
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and functional validation of SRC and RAPGEF1 as new direct targets of miR-203, involved in regulation of epidermal homeostasis. | Sci Rep | 2023 | 37635193 | PubTator, text mining | PubMed |
| Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling. | Molecules | 2023 | 37630370 | PubTator, text mining | PubMed |
| A Novel Multi-Component Formulation Reduces Inflammation In Vitro and Clinically Lessens the Symptoms of Chronic Eczematous Skin. | Int J Mol Sci | 2023 | 37629159 | PubTator, text mining | PubMed |
| Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates. | Biomedicines | 2023 | 37626650 | PubTator, text mining | PubMed |
| Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression. | Nat Commun | 2023 | 37626054 | PubTator, text mining | PubMed |
| Immunolocalization and Expression of JAK1 and JAK3 in the Skin of Dust Mite-Sensitive Beagle Dogs before and after Allergen Exposure. | Vet Sci | 2023 | 37624299 | PubTator, text mining | PubMed |
| Bioengineered skin organoids: from development to applications. | Mil Med Res | 2023 | 37605220 | PubTator, text mining | PubMed |
| Commensal Cutibacterium acnes induce epidermal lipid synthesis important for skin barrier function. | Sci Adv | 2023 | 37595033 | PubTator, text mining | PubMed |
| Cux1+ proliferative basal cells promote epidermal hyperplasia in chronic dry skin disease identified by single-cell RNA transcriptomics. | J Pharm Anal | 2023 | 37577389 | PubTator, text mining | PubMed |
| Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs. | Oncogene | 2023 | 37573406 | PubTator, text mining | PubMed |
| Recent Advances in Biodegradable and Biocompatible Synthetic Polymers Used in Skin Wound Healing. | Materials (Basel) | 2023 | 37570163 | PubTator, text mining | PubMed |
| In vivo efficacy proof of concept of a large-size bioprinted dermo-epidermal substitute for permanent wound coverage. | Front Bioeng Biotechnol | 2023 | 37560537 | PubTator, text mining | PubMed |
| Atopic dermatitis and gestational age - is there an association between them? A review of the literature and an analysis of pathology. | Postepy Dermatol Alergol | 2023 | 37545834 | PubTator, text mining | PubMed |
| Transplantation of human induced pluripotent stem cell derived keratinocytes accelerates deep second-degree burn wound healing. | World J Stem Cells | 2023 | 37545758 | PubTator, text mining | PubMed |
| Development of a novel microneedle platform for biomarker assessment of atopic dermatitis patients. | Skin Res Technol | 2023 | 37522507 | PubTator, text mining | PubMed |
| Dermal fibroblast cell-derived exosomes for atopic dermatitis: In-vitro test. | Skin Res Technol | 2023 | 37522488 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part III. | Rom J Morphol Embryol | 2023 | 37518868 | PubTator, text mining | PubMed |
| Anti-Inflammatory and Antiatopic Effects of Rorippa cantoniensis (Lour.) Ohwi in RAW 264.7 and HaCaT Cells. | Molecules | 2023 | 37513335 | PubTator, text mining | PubMed |
| Challenges and Future Trends in Atopic Dermatitis. | Int J Mol Sci | 2023 | 37511138 | PubTator, text mining | PubMed |
| Integration of Phenotype Term Prioritization and Gene Expression Analysis Reveals a Novel Variant in the PERP Gene Associated with Autosomal Recessive Erythrokeratoderma. | Genes (Basel) | 2023 | 37510397 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4014/papers?page=12